Clinical Trials Logo

Radiation Retinopathy clinical trials

View clinical trials related to Radiation Retinopathy.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02222610 Completed - Clinical trials for Radiation Retinopathy

Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy.

RRR
Start date: September 23, 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the tolerability and efficacy of ranibizumab treatment administered in subjects with radiation retinopathy

NCT ID: NCT01579760 Completed - Macular Edema Clinical Trials

Intravitreal Aflibercept Injection for Radiation Retinopathy

Start date: November 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety of intravitreal aflibercept injection - in the treatment of macular edema associated with retinopathy secondary to previous radiation therapy.

NCT ID: NCT01334879 Completed - Clinical trials for Radiation Retinopathy

High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy

Start date: May 2011
Phase: Phase 1
Study type: Interventional

This study investigates the use of a high dose anti-VEGF agent for the treatment of radiation retinopathy in those patients who have recalcitrant disease.

NCT ID: NCT00750399 Completed - Choroidal Melanoma Clinical Trials

Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma

Start date: October 2008
Phase: Phase 1
Study type: Interventional

This is a Phase I clinical trial to test the safety and tolerability of intravitreal ranibizumab in the treatment of radiation retinopathy following plaque brachytherapy for patients with choroidal melanoma using the incidence and severity of events criteria. The secondary objective is to assess the efficacy of intravitreal ranibizumab on regression of radiation retinopathy by ophthalmic examination, fundus photography, fluorescein angiography, and optical coherence tomography, as well as visual acuity.